Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06623318 · ClinicalTrials.gov registry record · NA
IV Ensure in Patients Receiving OPAT
A NA study of Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates, sponsored by IV Ensure.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06623318 is a NA study of Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates that is actively recruiting participants, run by IV Ensure. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06623318, a NA study of Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates, is actively recruiting participants, sponsored by IV Ensure.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of remote therapeutic monitoring is to provide oversight and evaluation of patients receiving IV medications in the home setting post-acute. The goal is to improve patient outcomes and decrease re-admission rates for related diagnoses due to poor adherence. Remote therapeutic monitoring provides data used in the determination of dates, times, and duration of doses administered in the home setting to support real-time intervention by dedicated care managers to support improved adherence with prescribed dosing regiments. The objectives of the study are to: 1. Determine adherence rates for IV medications administered in the home. 2. Assess re-admission against adherence rates.
Conditions Studied
Interventions
- DEVICE Remote therapeutic monitoring device
Study Locations (1)
Oklahoma
- The University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2024-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06623318
The ClinicalTrials.gov registry entry for NCT06623318 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is IV Ensure, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates appearing as the primary indexed condition, and to 1 intervention - of which Remote therapeutic monitoring device is the first listed.
NCT06623318 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06623318 about?
NCT06623318 is a clinical study titled "IV Ensure in Patients Receiving OPAT". The purpose of remote therapeutic monitoring is to provide oversight and evaluation of patients receiving IV medications in the home setting post-acute. The goal is to improve patient outcomes and decrease re-admission rates for related diagnoses due to poor adherence. Remote therapeutic monitoring ...
What is the current status of trial NCT06623318?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-08-23. Estimated completion is 2024-11.
What conditions does trial NCT06623318 study?
This clinical trial studies the following conditions: Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates.
What interventions are being tested in trial NCT06623318?
The interventions under investigation include: Remote therapeutic monitoring device (DEVICE).
Who is sponsoring clinical trial NCT06623318?
This trial is sponsored by IV Ensure, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06623318 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates
All registered trials for this condition
Oklahoma
All trials with a study site in Oklahoma
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.